Læknablaðið - 01.10.1979, Síða 57

LÆKNABLAÐIÐ
259
in a public school system. Am. J. Dis. Child.
123: 193—196, 1972.
71. Schiff G.M., Rauh J.L., Linnemann C.C.,
Shea L., Rotte T.C., Trimble S.: Rubella
vaccines in public school system. A 4%
year follow-up. Am. J. Dis. Child. 128: 180
—183, 1974.
72. Spruance S.L., Smith C.B.: Joint compli-
cations associated with derivates of HPV-
77 rubella virus vaccine. Am. J. Dis. Child.
122: 105—111, 1971.
73. Spruance S.L., Klock L.E., Bailey A., Vard
J.R., Smith C.B.: Recurrent joint symptoms
in children vaccinated with HPV-77 DK12
rubella vaccine. J. Pediatrics. 80: 413—417,
1972.
74. Spruance S.L., Metcalf R., Smith C.B.,
Griffiths M.M., Ward R.J.: Chronic art-
hropathy associated with rubella vaccina-
tion. Arthritis and Rheumatism. 20: 741—
747, 1977.
75. Stannegard Ö., Holm S.E., Hermodsson S.,
Norrby R., Lycke E.: Case of apparent
reinfection with rubella. Lancet Jan. 31.
240—241, 1970 (Let).
76. Thompson G.R., Ferreya A., Brackett R.G.:
Acute arthritis complicating rubella vacc-
ination. Arthritis and Rheumatism. 14: 19
—26, 1971.
77. Thompson G.R., Weiss J.J., Shillis J.L.,
Brackett R.G.: Intermittent atrhritis foll-
owing rubella vaccination. Am. J. Dis.
Child. 125: 526—530, 1973.
78. Tómasson H.O., ögmundsdóttir H.M.: Ru-
bella in Iceland. Acta Path. microbiol.
Scand. 83: 275—284, 1975.
79. Vaheri A., Vesikari T., Oker-Blom N.,
Seppala M., Parkman P.D., Veronelli J.,
Robbins F.C.: Isolation of attenunted ru-
bella-vaccine virus from human products
of conseption and uterine cervix. New Engl.
J. Med. 286: 1071—1074, 1972.
80. Wallace R.B., Isacson P.: Comparative tri-
al of HPV-77 DE5 and RA 27/3 live-att-
enuated rubella vaccines. Am. J. Dis. Child.
124: 536—538, 1972.
81. Weibel R.E., Stokes J., Buynak E.B., Hille-
man M.R., Live rubella vaccines in adults
and children. Am. J. Dis. Child. 118: 226
—229, 1969.
82. Weibel R.E., Stokes J., Buynak E.B., Hille-
man M.R.: Influence of age on clinical res-
ponse to HPV-77 duck rubella vaccine.
Jama. 222: 805—807, 1972.
83. Weinstein L., Chang T.W.: Rubella imm-
unization. New Engl. J. Med. 288: 100—
101, 1973.
84. Wilkins J., Leedom J.M., Salvatore M.A.,
Portnoy B.: Clinical rubella with arthritis
from reinfection. Ann. internal Med. 77:
930—932, 1972.
85. Wyll S.A., Herrmann K.L., Abrutyn E„
Murphy G.D., Witte J.J.: Rubella booster
immunization. Serologic response to a se-
cond dose of vaccine. Jama 216, 1451—
1453, 1971.
86. Wyll S.A., Herrmann K.L.: Inadvertent ru-
bella vaccination of pregnant women. Fetal
risk in 215 cases. Jama 225: 1472—1476, ’73.
87. Zealley H.: Rubella screening and immuni-
zation of school-girls: a long-term evalua-
tion. Brit. J. Prew. soc. Med. 28: 54—59,
1974.
LEIÐRÉTTIN GAR
í grein Sigurðar Guðmundssonar o. fl.,
3. tbl. 65. árg., slæddust tvær villur.
Á bls. 128 segir að meðaltal kólesteróls
hafi verið 225 mg./lOO ml. í hóprannsókn
Hjartaverndar. Hið rétta er 255 mg./lOO
ml.
Á mynd 2 bls. 125 hafa víxlast ferlar
karla og kvenna úr rannsókn Hjartavernd-
ar.
Myndina af líkani Borgarspítalans á for-
síðu 3. tbl. tók Dís Ragnheiður Atladóttir,